1203447-95-3 Usage
Description
Phenyl (S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate is an organic compound with a complex molecular structure, characterized by its isoquinoline core and phenyl substituents. It is a key intermediate in the synthesis of various pharmaceutical compounds due to its unique chemical properties and reactivity.
Uses
Used in Pharmaceutical Industry:
Phenyl (S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate is used as a key intermediate in the synthesis of solifenacin (S676700), a muscarinic M3 receptor antagonist. The application reason is its role in the development of medications for the treatment of urinary incontinence, where it helps to modulate the muscarinic receptors in the bladder, leading to improved control over urination.
Additionally, if there are other applications in different industries, they can be listed as follows:
Used in Chemical Research Industry:
Phenyl (S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate is used as a research compound for studying its chemical properties and potential applications in various fields, such as material science, medicinal chemistry, and drug discovery. The application reason is its unique structure and reactivity, which can provide insights into the development of new compounds and materials with specific properties and functions.
Check Digit Verification of cas no
The CAS Registry Mumber 1203447-95-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,3,4,4 and 7 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1203447-95:
(9*1)+(8*2)+(7*0)+(6*3)+(5*4)+(4*4)+(3*7)+(2*9)+(1*5)=123
123 % 10 = 3
So 1203447-95-3 is a valid CAS Registry Number.
1203447-95-3Relevant articles and documents
Process for the preparation of solifenacin
-
Page/Page column 3, (2009/08/18)
A process for the preparation of (1S,3′R)-quiniclidin-3′-yl-1-phenyl-3,4-dihydro-1H-isoquinolin-2-carboxylate, namely solifenacin, comprising the reaction of a compound of formula (IV) with a compound of formula (V), as herein defined, and the subsequent reaction with 3-quinuclidinol.
